These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 36156921)

  • 21. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Barberio B; Fairbrass KM; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?
    Sach J; Bolus R; Fitzgerald L; Naliboff BD; Chang L; Mayer EA
    Am J Gastroenterol; 2002 Dec; 97(12):3131-8. PubMed ID: 12492200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irritable bowel syndrome in children with chronic gastrointestinal symptoms in primary care.
    Hogervorst EM; Ganzevoort IN; Berger MY; Holtman GA
    Fam Pract; 2024 Jun; 41(3):292-298. PubMed ID: 37392047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
    Van Oudenhove L; Törnblom H; Störsrud S; Tack J; Simrén M
    Gastroenterology; 2016 Apr; 150(4):866-74. PubMed ID: 26602216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
    Su AM; Shih W; Presson AP; Chang L
    Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.
    Mearin F; Baró E; Roset M; Badía X; Zárate N; Pérez I
    Am J Gastroenterol; 2004 Jan; 99(1):113-21. PubMed ID: 14687152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
    Goodoory VC; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2023 May; 57(10):1083-1092. PubMed ID: 36914979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.
    Goodoory VC; Guthrie EA; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2023 Feb; 57(3):323-334. PubMed ID: 36544055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome.
    Tang YR; Yang WW; Wang YL; Lin L
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):702-7. PubMed ID: 22382707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
    Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognition of abdominal pain and abdominal discomfort in Chinese patients with irritable bowel syndrome with diarrhea.
    Lu J; Chen Y; Shi L; Li X; Fei G; Li J; Yang A; Fang X
    Biopsychosoc Med; 2023 Sep; 17(1):31. PubMed ID: 37684670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome.
    Portincasa P; Moschetta A; Baldassarre G; Altomare DF; Palasciano G
    World J Gastroenterol; 2003 Oct; 9(10):2293-9. PubMed ID: 14562396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.